Thiazolopyrimidines useful as TNFα inhibitors

Details Thiazolopyrimidines useful as TNFα inhibitors Thiazolopyrimidines useful as TNFα inhibitors

2005-08-16

2005-08-16

Berch, Mark L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

C514S260100, C544S255000, C544S244000

Reexamination Certificate

active

06930101

ABSTRACT:
The invention provides derivatives of thiazolo[4,5-dl]pyrimidine and their use as inhibitors of proinflammatory cytokines.

REFERENCES:
patent: 3127402 (1964-03-01), Pachter et al.
patent: 3594378 (1971-07-01), Laliberte et al.
patent: 3919201 (1975-11-01), Evans
patent: 4041167 (1977-08-01), Moser et al.
patent: 4091219 (1978-05-01), Denzel et al.
patent: 4103016 (1978-07-01), Moser et al.
patent: 4110451 (1978-08-01), Moser et al.
patent: 4111693 (1978-09-01), Wright et al.
patent: 4160768 (1979-07-01), Moser et al.
patent: 4175961 (1979-11-01), Wright et al.
patent: 4224334 (1980-09-01), Moser et al.
patent: 4510141 (1985-04-01), Heckendorn
patent: 4593095 (1986-06-01), Snyder et al.
patent: 4665182 (1987-05-01), Nichol et al.
patent: 4701455 (1987-10-01), Nichol et al.
patent: 4766133 (1988-08-01), Fischli et al.
patent: 4769377 (1988-09-01), Snyder et al.
patent: 4778806 (1988-10-01), Bender et al.
patent: 4794114 (1988-12-01), Bender et al.
patent: 4931437 (1990-06-01), Fedi et al.
patent: 4996208 (1991-02-01), Lindner et al.
patent: 5198547 (1993-03-01), Bailey et al.
patent: 5288721 (1994-02-01), Klein et al.
patent: 5294612 (1994-03-01), Bacon et al.
patent: 5317019 (1994-05-01), Bender et al.
patent: 5366978 (1994-11-01), Furukawa et al.
patent: 5424311 (1995-06-01), Billhardt-Troughton et al.
patent: 5521181 (1996-05-01), Meyer et al.
patent: 5593992 (1997-01-01), Adams et al.
patent: 5599813 (1997-02-01), Matsumoto et al.
patent: 5656644 (1997-08-01), Adams et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5670506 (1997-09-01), Leigh et al.
patent: 5750575 (1998-05-01), Klein et al.
patent: 5792767 (1998-08-01), Meyer et al.
patent: 5843943 (1998-12-01), Carson et al.
patent: 5877180 (1999-03-01), Linden et al.
patent: 2004/0038994 (2004-02-01), Wilson
patent: 2038922 (1971-03-01), None
patent: 0188150 (1986-07-01), None
patent: 0348746 (1990-01-01), None
patent: 0490181 (1992-06-01), None
patent: 0493682 (1992-07-01), None
patent: 0733633 (1996-09-01), None
patent: 0849256 (1998-06-01), None
patent: 08-092250 (1996-04-01), None
patent: 92/10190 (1992-06-01), None
patent: 92/21344 (1992-12-01), None
patent: 93/06090 (1993-04-01), None
patent: 93/16699 (1993-09-01), None
patent: 96/40143 (1996-12-01), None
patent: 97/25045 (1997-07-01), None
patent: 97/25047 (1997-07-01), None
patent: 97/25048 (1997-07-01), None
patent: 98/22464 (1998-05-01), None
patent: 98/52948 (1998-11-01), None
Benjamin K. Gill, “Diagram Representing the Roles of Cytokines in Inflammatory Responses” http://attila.stevens-tech.edu/chembio/bgill/L10K.html downloaded from the Internet Aug. 12, 2002.
Goncalves de Morales et al. Effects of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung. J. of Pharm. 117, pp. 1792-1796, 1996.
Chemical Abstracts, vol. 69, 36067 (1968).
Chemical Abstracts, vol. 72, 12658 (1970).
Abdel-Fattah, A.M., et al., “Reactions with 6-Methyl-2-Thiouracil Synthesis of Dipyrimidino[2,1-b:1′, 2′ -c]Thiazine. A New Ring System”,Phosphorus, Sulfur, and Silicon, 72, pp. 145-156, (1992).
Basyouni, W.M., et al., “Synthesis and Molluscicidal Properties of Some Newer Thiazoles and Their Thiazolo [5,4, -d] Pyrimidinone Derivatives”,Egypt. J. Bilh., 17, pp. 91-102, (1995).
Bruns, R.F., “Adenosine Antagonism by Purines, Pteridines and Benzopteridines in Human Fibroblasts”,Biochemical Pharmacology, 30, pp. 325-333, (1981).
Flammang, R., et al., “Iminoethenethiones, RN==C==C==S: Characterization by Neutralization-Reionization Mass Spectrometry and G2(MP2) Theory”,Journal of the American Chemical Society, 116(5), pp. 2005-2013, (1994).
Furrer, H., et al., “A new class of potent hypolipemic agents raising high-density lipoproteins. Synthesis, reactions and pharmacological properties”,Eur. J. Med. Chem., 29, pp. 819-829, (1994).
Ghoneim, K.M., et al., “Study on the Formation of Thiazolopyrimidinediones and Pyrimidothiazinediones from 6-Methyl-2-thiouracil”,Polich. J. Chem., 72, pp. 1173-1177, (1997).
Glennon, R.A., et al., “Alkylation Studies on 6-Ethyl-2,3-dihydrothiazolo-[3,2-α] pyrimidine-5,7-diones”,Journal of Heterocyclic Chemistry, 16(5), pp. 903-907, (Jul. 1979).
Goldman, I.M., “A Novel Thiazole Synthesis.4,5,6,7-Tetrahydrothiazolo[4,5-d]pyrimidine-5,7-diones”,The Journal of Organic Chemistry, 34(11), pp. 3285-3289, (Nov. 1969).
Grohe, K., et al., “Cycloacylierung von Enaminen, I Synthese von 2-Thiazolon-Derivaten”,Liebigs Ann. Chem., pp. 1018-1024, (1973).
Itoh, T., et al., “Synthesis of Some Tricyclic Heterocycles from 5,6-Diamino-1,3-dimethyluracil”,Chem. Pharm. Bull., 37(8), pp. 2197-2199, (Aug. 1989).
Kaul, R., et al., “2-14C-1-Allyl-3,5-diethyl-6-chlorouracil II: Isolation and Structures of the Major Sulfur-Free and Three Minor Sulfur-Containing Metabolites and Mechanism of Biotransformation”,Journal of Pharmaceutical Sciences, 71(8), pp. 897-900, (Aug. 1982).
Kaul, R., et al., “Mechanism of Formation of SCH3-Metabolites Investigated on the Biotransformation of 1-Allyl-3, 5-Diethyl-6-Chlorouracil in Rabbits”,Chemopshere, 10(8), pp. 929-934, (1981).
Komoriya, K., et al., “Characterization of Immunomodulating Action of TI-31 on Antibody Response in Mice”,J. Pharmacobio-Dyn., 14, pp. 443-447, (1991).
Lewis, A.F., et al., “Thiazolo[4,5-d]pyrimidines. Part I. Synthesis and Anti Human Cytomegalovirus (HCMV) Activity in vitro of Certain Alkyl Derivatives”,J. Heterocyclic Chem., 32, pp. 547-556, (Mar.-Apr. 1995).
Mbagwu, G.O., et al., “Carbon-13 Nuclear Magnetic Resonance Spectra of Some Mesoionic Xanthine Analogs”,Organic Magnetic Resonance, 21(9), pp. 527-531, (1983).
Mbagwu, G. O., “Studies of Amine-Induced Ring Opening of Some Mesoionic Xanthines”,J. Heterocyclic Chem., 22, pp. 465-474, (1985).
Mizuno, Y., et al., “Synthesis of a Potential Antitumor Agent: 4-(β-D-Ribofuransoyl)—4,5,6,7-tetrahydrothiazolo[4,5-d]pyrimidine-5,7-dione (Thioanalog of 3-Isoxanthosine)”,Chem. Pharm. Bull., 22(5), pp. 1198-1200, (1974).
Nagahara, K., et al., “Thiazolo[4 5-d]pyrimidine Nucleosides. The Synthesis of Certain 3-β-D-Ribofuranosylthiazolo[4,5-d]pyrimidines ad Potential Immunotherapeutic Agents”,J. Med. Chem., 33, pp. 407-415, (1990).
Sen, D., et al., “Effect of Mesoionic Xanthine Analogs onTrypanosoma musculiDevelopment in Mice”,J. Euk. Microl., 40(3), pp. 259-262, (1993).
Sudhakar Rao, T., et al., “Synthesis of 4,6-Disubstituted-7-β-D-ribofuranosyl- and Arabinofuranosylpyrazolo[3,4-d]pyrimidines and Cetain Related Ribonucleosides”,J. Heterocyclic Chem., 28, pp. 1779-1788, (1991).
Szajda, M., et al., “Reactions of 2-Thiothymine with Esters of Chloroacetic Acid”,Polish Journal of Chemistry, 52, pp. 1027-1031, (1983).
Takahashi, H., et al., “A One-Step Synthesis of Glycosylaminoisothiazolo[3,4-d] pyrimidines and Glycosylaminoisothiazoles”,Chem. Pharm. Bull., 27(5), pp. 1147-1152, (1979).
In:Remington's Pharmaceutical Sciences, Eighteenth Edition, Gennaro, A.R., (ed.), Mack Publishing Company, Easton, PA, p. 391 (1990).
In:Remington's Pharmaceutical Sciences, Eighteenth Edition, Gennaro, A.R., (ed.), Mack Publishing Company, Easton, PA, p. 1115-1121, (1990).
Badger, A.M., et al., “Pharmacological Profile of SB 203580, a Selective Inhibitor of Cytokine Suppressive Binding Protein/p38 Kinase, in Animal Models of Arthritis, Bone Resorption, Endotoxin Shock and Immune Function”,The Journal of Pharmacology and Experimental Therapeutics, 279, 1453-1461, (1996).
Baker, J.A., et al., “Synthesis of Derivatives of Thizolo[4,5-d]pyrimidine. Part II”,Journal of the Chemical Society(C),18, 2478-2484, (1970).
Boehm, J.C., et al., “1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipox

Affiliated with

Also associated with

Rating

Thiazolopyrimidines useful as TNFα inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolopyrimidines useful as TNFα inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolopyrimidines useful as TNFα inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3464466